MedPath

APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE

APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE

Approved
DIN Number

02509415

Drug Class

Human

Market Date

Nov 7, 2022

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02509415
AIG Number0252656001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BD07 METFORMIN AND SITAGLIPTIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.05
Health Canada Classification

ACTIVE INGREDIENTS (2)

METFORMIN HYDROCHLORIDEActive
Strength: 500 MG
Monograph: METFORMIN HYDROCHLORIDE
SITAGLIPTIN (SITAGLIPTIN MALATE)Active
Strength: 50 MG
Monograph: SITAGLIPTIN (SITAGLIPTIN MALATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.